FASENRA 30 mg/mL

FASENRA 30 mg/mL is a subcutaneous injection solution containing benralizumab, used for managing asthma and related conditions. This medication is designed to help control symptoms and improve respiratory function.

FASENRA 30 mg/mL is primarily used for the maintenance treatment of severe eosinophilic asthma in adults and pediatric patients. It works by targeting and reducing eosinophils, a type of white blood cell involved in asthma inflammation. Patients often wonder, 'What is FASENRA used for?' This medication is intended for those who have not responded well to other asthma treatments.

Common effects of FASENRA 30 mg/mL may include reactions at the injection site, such as redness, swelling, or itching. Some users might experience headaches or fatigue. These effects are generally mild and temporary, but any persistent or severe symptoms should be discussed with a healthcare provider.

FASENRA 30 mg/mL should be stored at room temperature and protected from light. It is important to use this medication exactly as prescribed. Patients with a history of allergic reactions to benralizumab or any of its components should avoid using this medication. Always consult a healthcare professional before starting any new treatment.

FASENRA 30 mg/mL may interact with other medications, including those that suppress the immune system. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect how this medication works, so it is advisable to discuss your diet and lifestyle with your healthcare provider.